Outcomes of Glaucoma Drainage Device Surgery in Eyes with Treated Uveal Melanoma
Conclusions: Our case series with a median follow-up of 2 years shows that placing a GDD in patients with treated uveal melanoma does not expose patients to greater risk of local or extraocular recurrence. A larger series and longer follow-up time are required to fully evaluate the safety of GDDs in this clinical scenario.Ocul Oncol Pathol
Source: Ocular Oncology and Pathology - Category: Opthalmology Source Type: research
More News: Cancer & Oncology | Eye Cancers | Eyes | Genetics | Glaucoma | Liver | Melanoma | Opthalmology | Pathology | Skin Cancer | Urology & Nephrology | Uveal Melanoma